Johnson And Johnson Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Johnson And Johnson's inventory turnover ratio sequentially decreased to 2.17 in the second quarter 2026, unsurprisingly, as the Johnson And Johnson markets continue to deteriorate, and JNJ's faces growing challenges to bring down its inventories. Johnson And Johnson's average inventory processing period in the Jun 28 2026 quarter, has increased to 168 days, from 166 days, in the Mar 29 2026 quarter.

Within Healthcare sector 180 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 101 in the first quarter 2026, to 1476.

JNJ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Johnson And Johnson Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

JNJ Inventory Turnover Ratio	(Jun 28 2026) II. Quarter	(Mar 29 2026) I. Quarter	(Dec 28 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Inventory Growth	12.91 %	15.2 %	14.04 %	12.24 %	10.21 %
Y / Y Cost of Sales Growth	5.55 %	10.18 %	11.78 %	4.88 %	11.05 %
Inventory Turnover Ratio (TTM)	2.17	2.2	2.22	2.23	2.28
JNJ's Total Ranking	# 1476	# 101	# 294	# 83	# 126
Average inventory processing period	169	166	164	163	160
Seq. Inventory Growth	3.85 %	2.76 %	0.32 %	5.47 %	5.95 %
Seq. Cost of Sales Growth	-0.68 %	1.73 %	9.11 %	-4.26 %	3.68 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 49
Healthcare Sector	# 181
Overall Market	# 1476

Inventory Turnover Ratio Statistics
High	Average	Low
3.64	2.9	2
(Sep. 30, 2010)		(Sep 29 2024)

JNJ Company Profile >> Back to JNJ Efficiency Comparisons >> Compare JNJ Inventory Turnover Ratio to its Competitors

Financial Statements
Johnson And Johnson's Inventories	$ 15,144 Millions	Visit JNJ's Balance sheet
Johnson And Johnson's Cost of Revenues TTM	$ 31,428 Millions	Visit JNJ's Income Statement
What are JNJ's Sales?		Visit JNJ's Sales by Segment

Other Inventory Turnover Ratios
Johnson And Johnson's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
JNJ's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for JNJ's Competitors
Inventory Turnover Ratio for JNJ's Suppliers
Inventory Turnover Ratio for JNJ's Customers

You may also want to know
JNJ's Sales Growth Rates	JNJ's Pe Price to earnings ratio	JNJ's Receivables Turnover Ratio	JNJ's Stock Quote
JNJ's Net Income Growth Rates	JNJ's Ps Price to Sales ratio	JNJ's Sales per Employee	JNJ's Asset Turnover Ratio
JNJ's Net Margin	JNJ's Pb Price to Book ratio	JNJ's Financial Strength Ratios	JNJ's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 28 2026	Inventories at quarter ending Jun 28 2026
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Cg Oncology Inc	5.47	$ 7.609 Millions	$ 1 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Collegium Pharmaceutical Inc	4.99	$ 293.290 Millions	$ 59 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Vericel Corporation	4.30	$ 77.922 Millions	$ 18 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Coherus Oncology inc	4.03	$ 15.822 Millions	$ 4 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions

Date modified: 2026-09-05T07:03:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.